| Insulin |
Insulin |
|
|
Insulin |
| Amylin analogs (Pramlintide) |
Amylin analogs (Pramlintide) |
|
|
Amylin analogs (Pramlintide) |
| Sulfonylureas (glimepiride, glipizide, glyburide, others) |
Sulfonylureas (glimepiride, glipizide, glyburide, others) |
|
|
Sulfonylureas (glimepiride, glipizide, glyburide, others) |
| Meglitinides (nateglinide, repaglinide) |
Meglitinides (nateglinide, repaglinide) |
|
|
Meglitinides (nateglinide, repaglinide) |
| Biguanides (metformin) |
Biguanides (metformin) |
|
|
Biguanides (metformin) |
| Thiazolidinediones (pioglitazone, rosiglitazone) |
Thiazolidinediones (pioglitazone, rosiglitazone) |
|
|
Thiazolidinediones (pioglitazone, rosiglitazone) |
| Alpha-glucosidase inhibitors (acarbose, miglitol) |
Alpha-glucosidase inhibitors (acarbose, miglitol) |
|
|
Alpha-glucosidase inhibitors (acarbose, miglitol) |
| Dipeptidyl peptidase inhibitors (alogliptin, linagliptin, others) |
Dipeptidyl peptidase inhibitors (alogliptin, linagliptin, others) |
|
|
Dipeptidyl peptidase inhibitors (alogliptin, linagliptin, others) |
| Sodium-glucose co-transporter 2 inhibitors (canagliflozin, dapagliflozin, others) |
Sodium-glucose co-transporter 2 inhibitors (canagliflozin, dapagliflozin, others) |
|
|
Sodium-glucose co-transporter 2 inhibitors (canagliflozin, dapagliflozin, others) |
| Oral combination drugs |
Oral combination drugs |
|
|
Oral combination drugs |
| Other, specify |
Other, specify |
|
|
Other, specify |